Found 31 matching trials
Tarlatamab Treatment Before and After Surgery in Surgically Resectable Recurrent High-grade Glioma: a Window of Opportunity Study (TARLAGLIA Study)
PHASE1This is a single-arm, window-of-opportunity clinical study evaluating tarla...
Location
Hospital Universitari Vall D Hebron
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
PHASE3The main objective is to compare the efficacy of tarlatamab with standard o...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Tarlatamab in Recurrent Gynecological Neuroendocrine Carcinomas: A Phase II Proof-of-concept Study
PHASE2Neuroendocrine carcinoma of the cervix (NECC) is an aggressive histological...
Location
Hôpitaux Universitaires de Strasbourg
Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
PHASE2This is an open-label, phase II, exploratory and multi-centre clinical tria...
Location
Hospital General Universitario de Albacete
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
PHASE3The primary objective of this study is to compare the efficacy of tarlatama...
Status
Active Not Recruiting
Location
Valkyrie Clinical Trials
A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC
PHASE2The primary objective of this study is to describe the antitumor activity o...
Status
Active Not Recruiting
Location
University of California Los Angeles
SCLC Tarlatamab Blood Collection
N/AThe overall objective of this project is to prospectively collect blood sam...
Location
Multiple Locations
Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer
PHASE3Eligible participants with limited stage-small cell lung cancer (LS-SCLC) w...
Location
Multiple Locations
A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2
PHASE2START-lung is an international, multicentre, single-arm phase II trial. Pro...
Tarlatamab for Advanced Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma (TAURUS)
PHASE2Extrapulmonary small cell carcinoma (EPSCC) or neuroendocrine carcinoma (NE...
Location
National Taiwan University Hospital